Menu
Recruiting NCT07303153

Assessment of Quality of Life After Acute Mesenteric Ischemia

Observational Acute Mesenteric Ischemia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Acute Mesenteric Ischemia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Acute mesenteric ischemia is a severe abdominal emergency associated with a poor prognosis. While numerous studies have been conducted on the incidence, outcomes, and risk factors of mesenteric ischemia, very few focus on the quality of life of patients.

Primary outcome measures

  • Score of GIQLI (Gastrointestinal Quality of Life Index) [Time frame: Up to 12 months]

Eligibility criteria

Inclusion criteria

  • Adult patient (≥ 18 years)
  • Treated for mesenteric ischemia between 2010 and 2022 in the intensive care, cardiovascular, and digestive and vascular surgery departments of the Strasbourg University Hospitals

Exclusion criteria

  • Chronic mesenteric ischemia or other non-ischemic intestinal vascular pathologies such as mechanical causes.
  • Colonic ischemia

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

France · 1 center
  • Service d'Anesthésie - CHU de Strasbourg - France — Strasbourg

Identifiers

NCT: NCT07303153 · 9481

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗